GF Fund Management’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,306
Closed -$35.5K 636
2025
Q4
$35.5K Sell
2,306
-217
-9% -$2.39K ﹤0.01% 443
2025
Q3
$25.1K Sell
2,523
-843
-25% -$8.77K ﹤0.01% 464
2025
Q2
$33.4K Hold
3,366
﹤0.01% 449
2025
Q1
$43.7K Buy
3,366
+606
+22% +$8.02K ﹤0.01% 432
2024
Q4
$35.2K Buy
+2,760
New +$33.4K ﹤0.01% 422

Other funds holding DVAX

GF Fund Management's DVAX Position: Q1 2026 in Review

GF Fund Management sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 2,306 shares — an estimated $35.5K sold.

GF Fund Management first reported a position in DVAX in Q4 2024 and held it in 5 quarters. The position peaked at $43.7K in Q1 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • GF Fund Management reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • GF Fund Management sold 2,306 Dynavax Technologies shares in Q1 2026, an estimated $35.5K.
  • GF Fund Management first reported a position in Dynavax Technologies in Q4 2024 and held it in 5 quarters.
  • GF Fund Management's Dynavax Technologies position peaked at $43.7K in Q1 2025.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on GF Fund Management's 13F filing for Q1 2026, filed 15 Apr 2026.